Health Condition 1: B070- Plantar wart
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Patients aged between 18 to 65 years of both sexes with plantar warts. 2.Patients who have not been treated either systemically or topically, or stopped treatment or failed to achieve adequate results within the past 4 weeks. 3.Patients who are willing to sign the written consent form prior to participation in the study.
Exclusion criteria
Exclusion criteria: 1.Patients with fever or sign of any local inflammation or infection. 2.Patients with bleeding disorders. 3.Pregnant or lactating females. 4.Patients with a history of known hypersensitivity or allergy to Bleomycin and Tretinoin. 5.Immunocompromised patients.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To compare the therapeutic efficacy and safety of microneedling with Tretinoin versus microneedling with Bleomycin in plantar warts.Timepoint: 1 year | — |
Secondary
| Measure | Time frame |
|---|---|
| 1.To evaluate the therapeutic efficacy and safety of microneedling with Tretinoin in plantar warts. 2.To evaluate the therapeutic efficacy and safety of microneedling with Bleomycin in plantar warts. Timepoint: 1 year | — |
Countries
India
Contacts
Guru Gobind Singh Medical College